Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reo Tanoshima

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer|July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trialMasahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
Therapeutic Innovation & Regulatory Science|September 3, 2024
Using a Quality Management System and Risk-based Approach in Observational Studies to Obtain Robust Real-World EvidenceReo Tanoshima, Naoko Inagaki, Manabu Nitta, et al.
Hematological Oncology|November 17, 2022
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working groupRyu Yanagisawa, Masaharu Tamaki, Reo Tanoshima, et al.
Journal of Clinical Immunology|January 4, 2022
Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other than Severe Combined Immunodeficiency in Japan: Retrospective Analysis for 1985-2016Satoshi Miyamoto, Katsutsugu Umeda, Mio Kurata, et al.
Cytotherapy|December 18, 2023
Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular TherapyHiromi Hayashi, Makoto Iwasaki, Hideki Nakasone, et al.
International Journal of Hematology|December 14, 2022
Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndromeMasahiro Irie, Tetsuya Niihori, Tomohiro Nakano, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer|July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trialMasahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
Therapeutic Innovation & Regulatory Science|September 3, 2024
Using a Quality Management System and Risk-based Approach in Observational Studies to Obtain Robust Real-World EvidenceReo Tanoshima, Naoko Inagaki, Manabu Nitta, et al.
Hematological Oncology|November 17, 2022
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working groupRyu Yanagisawa, Masaharu Tamaki, Reo Tanoshima, et al.
Journal of Clinical Immunology|January 4, 2022
Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other than Severe Combined Immunodeficiency in Japan: Retrospective Analysis for 1985-2016Satoshi Miyamoto, Katsutsugu Umeda, Mio Kurata, et al.
Cytotherapy|December 18, 2023
Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular TherapyHiromi Hayashi, Makoto Iwasaki, Hideki Nakasone, et al.
International Journal of Hematology|December 14, 2022
Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndromeMasahiro Irie, Tetsuya Niihori, Tomohiro Nakano, et al.
Pageof 5